Assessing Bleeding Rates, Related Clinical Impact and Factor Utilization in German Hemophilia B Patients Treated With Extended Half-Life rIX-FP Compared to Prior Drug Therapy
Current Medical Research and Opinion - United Kingdom
doi 10.1080/03007995.2019.1662675
Full Text
Open PDFAbstract
Available in full text
Categories
Date
September 13, 2019
Authors
Publisher
Informa UK Limited